Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Oct 2;2(4):e146.
doi: 10.1002/pcn5.146. eCollection 2023 Dec.

Ayahuasca: A review of historical, pharmacological, and therapeutic aspects

Affiliations
Review

Ayahuasca: A review of historical, pharmacological, and therapeutic aspects

Simon G D Ruffell et al. PCN Rep. .

Abstract

Ayahuasca is a psychedelic plant brew originating from the Amazon rainforest. It is formed from two basic components, the Banisteriopsis caapi vine and a plant containing the potent psychedelic dimethyltryptamine (DMT), usually Psychotria viridis. Here we review the history of ayahuasca and describe recent work on its pharmacology, phenomenological responses, and clinical applications. There has been a significant increase in interest in ayahuasca since the turn of the millennium. Anecdotal evidence varies significantly, ranging from evangelical accounts to horror stories involving physical and psychological harm. The effects of the brew on personality and mental health outcomes are discussed in this review. Furthermore, phenomenological analyses of the ayahuasca experience are explored. Ayahuasca is a promising psychedelic agent that warrants greater empirical attention regarding its basic neurochemical mechanisms of action and potential therapeutic application.

Keywords: DMT; ayahuasca; ceremony; harmala alkaloids; psychedelic.

PubMed Disclaimer

Conflict of interest statement

Simon G. D. Ruffell, Nige Netzband, and WaiFung Tsang are directors of a not‐for‐profit research institute. Jerome Sarris and Daniel Perkins are directors of a not‐for‐profit medicinal psychedelics research institute. Simon G. D. Ruffell, Tessa Cowley‐Court, and Diana McHerron are employed at this not‐for‐profit medicinal psychedelics research institute. Jerome Sarris is supported by an National Health and Medical Research Council (NHMRC) Clinical (Fellowship APP1125000).

References

    1. Tupper KW. Ayahuasca healing beyond the Amazon: the globalization of a traditional indigenous entheogenic practice. Glob Netw. 2009;9(1):117–136.
    1. Santos Rd, Landeira‐Fernandez J, Strassman RJ, Motta V, Cruz A. Effects of ayahuasca on psychometric measures of anxiety, panic‐like and hopelessness in Santo Daime members. J Ethnopharmacol. 2007;112(3):507–513. - PubMed
    1. Rivier L, Lindgren J‐E. “Ayahuasca,” the South American hallucinogenic drink: an ethnobotanical and chemical investigation. Econ Bot. 1972;26(2):101–129. 10.1007/bf02860772 - DOI
    1. Spruce R. On some remarkable narcotics of the Amazon Valley and Orinoco. Geogr Rev. 1873;1(55):184–193.
    1. Miller MJ, Albarracin‐Jordan J, Moore C, Capriles JM. Chemical evidence for the use of multiple psychotropic plants in a 1,000‐year‐old ritual bundle from South America. Proc Natl Acad Sci USA. 2019;116(23):11207–11212. - PMC - PubMed